Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter, open-label, randomized, parallel controlled, community trial

Yupeng Wang; Qingbo Guan; Xu Hou; Xu Zhang; Haiqing Zhang; Chao Xu; Fei Jing; Shizhan Ma; Shanshan Shao; Meng Zhao; Qingling Guo; Fang Zhong; Ling Gao; Jiajun Zhao; MIDiab Study Group

doi:10.1111/1753-0407.13081

Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter, open-label, randomized, parallel controlled, community trial

J Diabetes. 2020 Nov;12(11):862-864. doi: 10.1111/1753-0407.13081. Epub 2020 Jul 19.

Authors

Yupeng Wang^{1

2

3}, Qingbo Guan^{1

2

3

4}, Xu Hou^{1

2

3}, Xu Zhang^{1

2

3}, Haiqing Zhang^{1

2

3}, Chao Xu^{1

2

3}, Fei Jing^{1

2

3}, Shizhan Ma^{1

2

3}, Shanshan Shao^{1

2

3}, Meng Zhao^{1

2

3}, Qingling Guo^{1

2

3}, Fang Zhong^{1

2

3}, Ling Gao^{2

3

4}, Jiajun Zhao^{1

2

3

4}; MIDiab Study Group

Affiliations

¹ Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
² Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, China.
³ Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, China.
⁴ Department of Scientific Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

PMID: 32609412
DOI: 10.1111/1753-0407.13081

No abstract available

Publication types

Letter
Multicenter Study
Randomized Controlled Trial

MeSH terms

Adult
Aged
Blood Glucose / metabolism
Combined Modality Therapy
Community-Based Participatory Research / methods*
Diabetes Complications / diagnosis
Diabetes Complications / prevention & control
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / therapy*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Life Style*
Lipids / blood
Male
Middle Aged
Outcome Assessment, Health Care / methods
Outcome Assessment, Health Care / statistics & numerical data
Self Care / methods*

Substances

Blood Glucose
Hypoglycemic Agents
Lipids

Grants and funding

2017YFC1309800/National Key Research and Development Program of China